The Future Of Biomedical Funding Depends On You

Americans today live longer and are healthier in general than any other time in history. Much of this success is due to the government's willingness to strongly support biomedical research. Unfortunately, this support is constantly under attack despite rapid advances in molecular technology that potentially could offer medical treatments or cures. Traditionally, biomedical scientists and physicians have not been effective as political activists. As a group we have been more involved in runnin

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Americans today live longer and are healthier in general than any other time in history. Much of this success is due to the government's willingness to strongly support biomedical research. Unfortunately, this support is constantly under attack despite rapid advances in molecular technology that potentially could offer medical treatments or cures.

Traditionally, biomedical scientists and physicians have not been effective as political activists. As a group we have been more involved in running our laboratories, minding our own business, and assuming that the rest of the world would appreciate our lofty altruism enough to keep those research dollars rolling in.

If this quiet self-absorption worked in the past, it certainly does not today. Scientists and physician- investigators are under unprecedented pressure to scrounge for research dollars and justify their professional existence. Case in point: Only about 10 percent to 20 percent of submitted research applications are currently funded, meaning that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Raymond Dubois

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo